Arthur J. Gallagher & Co. vs Takeda Pharmaceutical Company Limited
Market cap comparison over time
Arthur J. Gallagher & Co.
$73.6B
Rank #217
Takeda Pharmaceutical Company Limited
$74.9B
Rank #213
Market Cap Over Time
Key Moments
- Arthur J. Gallagher & Co. overtook Takeda Pharmaceutical Company Limited by 2021
- Takeda Pharmaceutical Company Limited overtook Arthur J. Gallagher & Co. by 2026
Year-by-Year Comparison
| Year | Arthur J. Gallagher & Co. | Takeda Pharmaceutical Company Limited | Leader |
|---|---|---|---|
| 2026 | $73.6B | $74.9B | Takeda Pharmaceutical Company Limited |
| 2025 | $65.9B | $50.3B | Arthur J. Gallagher & Co. |
| 2024 | $71.7B | $41.6B | Arthur J. Gallagher & Co. |
| 2023 | $56.4B | $38.6B | Arthur J. Gallagher & Co. |
| 2022 | $46.7B | $37.6B | Arthur J. Gallagher & Co. |
| 2021 | $41.5B | $27.3B | Arthur J. Gallagher & Co. |
| 2020 | $29.8B | $31.2B | Takeda Pharmaceutical Company Limited |
| 2019 | $22.6B | $34.2B | Takeda Pharmaceutical Company Limited |
| 2018 | $17.1B | $28.0B | Takeda Pharmaceutical Company Limited |
| 2017 | $14.4B | $46.8B | Takeda Pharmaceutical Company Limited |
| 2016 | $11.5B | $34.2B | Takeda Pharmaceutical Company Limited |
| 2015 | $8.7B | $41.4B | Takeda Pharmaceutical Company Limited |
| 2014 | $9.7B | $33.1B | Takeda Pharmaceutical Company Limited |
| 2013 | $9.4B | $30.8B | Takeda Pharmaceutical Company Limited |
| 2012 | $6.8B | $23.7B | Takeda Pharmaceutical Company Limited |
| 2011 | $6.2B | $19.8B | Takeda Pharmaceutical Company Limited |
| 2010 | $5.2B | $22.3B | Takeda Pharmaceutical Company Limited |
| 2009 | $3.8B | $20.5B | Takeda Pharmaceutical Company Limited |
| 2008 | $4.1B | $23.7B | Takeda Pharmaceutical Company Limited |
| 2007 | $3.7B | $32.5B | Takeda Pharmaceutical Company Limited |
| 2006 | $4.3B | $39.6B | Takeda Pharmaceutical Company Limited |
| 2005 | $4.3B | $30.4B | Takeda Pharmaceutical Company Limited |
| 2004 | $4.4B | $24.2B | Takeda Pharmaceutical Company Limited |
| 2003 | $4.2B | $19.6B | Takeda Pharmaceutical Company Limited |
| 2002 | $3.7B | $22.5B | Takeda Pharmaceutical Company Limited |
| 2001 | $4.3B | $26.6B | Takeda Pharmaceutical Company Limited |
| 2000 | $3.9B | $30.0B | Takeda Pharmaceutical Company Limited |